This year was a pivot year for us. We switched from being seen as a young start-up to be recognised as a leading biomodelling company in the biotech sector. Indeed, how could we be young when:

• We signed 26 clients worldwide with leader companies and many start-ups: see our last communication with PURATOS and UGent.
• We are on track for + 67% sales growth this year! Close to our breakeven!
• Average order of our customers has grown by +122%
• We have high firepower! With a team of 12 (10 permanents) talented modelers and developers.
• We are invited speakers in plenary of main biotech conferences to talk about the digital transformation of the biotech sector.

Today, we succeed in the industrialisation of biomodelling without compromise on high-quality.

• 51 mathematical models (digital twins) are in production in our pipeline: +141% compared to all the models we delivered during our first 3 years.
• This year, we delivered top notch pioneer models like:
  • Prediction of intracellular diffusion of biostimulants in crop species from foliar application
  • Sophisticated genome-scale metabolic models embedded with cellular burden, protein secretion machinery, regulatory networks, kinetics models of pathways, etc.
  • We identified bottlenecks and found solutions for 4 major bioprocess projects!

Don’t hesitate to contact us if you want to evaluate how we could set up your modelling platform!